Metrochem API Private Limited Metrochem API Private Limited

X

CAS 116091-63-5 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 116091-63-5
Also known as: 116091-63-5, 5-acetonyl-2-methoxybenzene sulfonamide, 5-acetonyl-2-methoxybenzenesulfonamide, Benzenesulfonamide, 2-methoxy-5-(2-oxopropyl)-, 5-(2-oxypropyl)-2-methoxy benzene sulphonamide, 2-methoxy-5-(2-oxopropyl)benzene-1-sulfonamide
Molecular Formula
C10H13NO4S
Molecular Weight
243.28  g/mol
InChI Key
MQQJFLHZXQRKKJ-UHFFFAOYSA-N

1 2D Structure

CAS 116091-63-5

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-methoxy-5-(2-oxopropyl)benzenesulfonamide
2.1.2 InChI
InChI=1S/C10H13NO4S/c1-7(12)5-8-3-4-9(15-2)10(6-8)16(11,13)14/h3-4,6H,5H2,1-2H3,(H2,11,13,14)
2.1.3 InChI Key
MQQJFLHZXQRKKJ-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC(=O)CC1=CC(=C(C=C1)OC)S(=O)(=O)N
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 116091-63-5

2. 5-acetonyl-2-methoxybenzene Sulfonamide

3. 5-acetonyl-2-methoxybenzenesulfonamide

4. Benzenesulfonamide, 2-methoxy-5-(2-oxopropyl)-

5. 5-(2-oxypropyl)-2-methoxy Benzene Sulphonamide

6. 2-methoxy-5-(2-oxopropyl)benzene-1-sulfonamide

7. 2-methoxy-5-(2-oxo-propyl)benzenesulfonamide

8. Mfcd07782136

9. Nadifloxacin Api

10. 2-methoxy-5-(2-oxopropyl)phenylsulfonamide

11. Benzenesulfonamide,2-methoxy-5-(2-oxopropyl)-

12. Ec 601-411-3

13. Schembl48765

14. Dtxsid60557085

15. Act01905

16. Bcp15013

17. Zinc21986557

18. Akos015837670

19. Ac-5616

20. Cs-w022283

21. Ds-1761

22. Sb30941

23. Sy021405

24. Db-041303

25. Ft-0642827

26. 2-methoxy-5-(2-oxo-propyl)-benzenesulfonamide

27. 2-methoxy-5-(2-oxopropyl)-benzene Sulfonamide

28. O10817

29. 091m635

30. A803554

31. J-003381

32. 2-methoxy-5-(2-oxo-propyl)benzenesulfonamide, Aldrichcpr

2.3 Create Date
2007-02-09
3 Chemical and Physical Properties
Molecular Weight 243.28 g/mol
Molecular Formula C10H13NO4S
XLogP30.1
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count5
Rotatable Bond Count4
Exact Mass243.05652907 g/mol
Monoisotopic Mass243.05652907 g/mol
Topological Polar Surface Area94.8 Ų
Heavy Atom Count16
Formal Charge0
Complexity346
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag India
Digital Content Digital Content
URL Supplier Web Content
3259-03-8
Tamsulosin
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderaba...
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
169506-15-4
Tamsulosin
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderaba...
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
112101-81-2
Tamsulosin
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderaba...
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY